Home / NUMIF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NUMIF make money? Does NUMIF have pricing power? What's the Earnings Whisper? Will NUMIF profit more as the business scales? What is NUMIF's management track record? Is NUMIF's current price justified?

Numinus Wellness Inc.

$0.03 -$0.01 (-23.66%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.03

Day Range

$0.02$0.03

Year Range

$0.01$0.06

Market Cap

9.62M

AVG Volume

123.03K

Trailing/Forward PE

-0.75/2.95

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-10-28

Primary Exchange

Other OTC

Revenue (CAD)

NUMIF Revenue (CAD) by year
Period	Revenue (CAD)
2025	7.66M
2024	1.31M
2023	23.18M
2022	6.49M
2021	1.51M
2020	881.18K
2019	107.48K

Net Income (CAD)

NUMIF Net Income (CAD) by year
Period	Net Income (CAD)
2025	-3.43M
2024	-19.64M
2023	-29.73M
2022	-60.65M
2021	-18.77M
2020	-9.6M
2019	-7.21M

Operating Income (CAD)

NUMIF Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	-3.54M
2024	-33.35M
2023	-25.95M
2022	-28M
2021	-16.07M
2020	-7.28M
2019	-6.34M

EBITDA (CAD)

NUMIF EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	-10.83M
2024	-13.94M
2023	-23.21M
2022	-27.53M
2021	-15.31M
2020	-10.3M
2019	-6.8M

Cash Flows (CAD)

NUMIF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	-1.81M
2024	-18.18M
2023	-23.14M
2022	-27.48M
2021	-16.22M
2020	-5.39M
2019	-4.64M

EPS (CAD)

NUMIF EPS (CAD) by year
Period	EPS (CAD)
2025	-0.01
2024	-0.07
2023	-0.11
2022	-0.26
2021	-0.11
2020	-0.12
2019	-0.11

Expenses (CAD)

NUMIF Expenses (CAD) by year
Period	Expenses (CAD)
2025	7.25M
2024	13.2M
2023	34.07M
2022	30.49M
2021	15.96M
2020	7.14M
2019	6.44M

Cash & Debt (CAD)

NUMIF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	469.64K
2024	1.96M
2023	8.58M
2022	33.04M
2021	59.29M
2020	1.63M
2019	89.99K

Debt ratios

NUMIF Debt ratios by year
Period	Debt ratios
2025	-0.02
2024	-0
2023	0.02
2022	0.42

Margins

NUMIF Margins by year
Period	Margins
2025	48.23%
2024	26.48%
2023	36.11%
2022	27.36%
2021	-5.39%
2020	9.99%
2019	-234.91%

Return on Capital

NUMIF Return on Capital by year
Period	Return on Capital
2025	107.96%
2024	-2707.75%
2023	-211.59%
2022	-147.15%
2021	-30.86%
2020	-342.94%
2019	-527.58%

Shares Outstanding

NUMIF Shares Outstanding by year
Period	Shares Outstanding
2025	320.55M
2024	295.14M
2023	266.46M
2022	243.08M
2021	194.57M
2020	95.21M
2019	73.84M

Book Value Per Share (CAD)

NUMIF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	-0.01
2024	0
2023	0.05
2022	0.17
2021	0.31
2020	0.03
2019	0.02

Total Assets (CAD)

NUMIF Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	3.82M
2024	10.77M
2023	24.33M
2022	52.63M
2021	64.14M
2020	5.12M
2019	3.08M

PE Ratio

NUMIF PE Ratio by year
Period	PE Ratio
Sep 26	1.75
Sep 26	1.97
Aug 26	2.42
Aug 26	2.47
Aug 26	2.28
Aug 26	2.21
Jul 26	1.93
Jul 26	2.52
Jul 26	2.45
Jul 26	1.91
Jul 26	1.34
Jun 26	1.37
Jun 26	1.27
Jun 26	1.51
Jun 26	1.5
May 26	1.44

Free Cash Flow Yield

NUMIF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	9.98%
Sep 26	8.9%
Aug 26	11.38%
Aug 26	11.17%
Aug 26	12.08%
Aug 26	12.47%
Jul 26	14.25%
Jul 26	10.94%
Jul 26	11.25%
Jul 26	14.44%
Jul 26	20.56%
Jun 26	20.07%
Jun 26	21.76%
Jun 26	18.25%
Jun 26	18.39%
May 26	19.15%
May 26	-11.77%
May 26	-13.54%
May 26	-10.92%
May 26	-21.97%
Apr 26	-12.11%
Apr 26	-56.79%
Apr 26	-59.92%
Apr 26	-56.45%
Mar 26	-59.7%
Mar 26	-24.73%
Mar 26	-20.45%
Mar 26	-19.35%
Feb 26	-12.91%
Feb 26	-12.09%
Feb 26	-12.86%
Feb 26	-12.76%
Jan 26	-12.74%
Jan 26	-10.55%
Jan 26	-12.05%
Jan 26	-11.1%
Jan 26	-10.45%
Dec 25	-11.91%
Dec 25	-11.35%
Dec 25	-12.36%
Dec 25	-12.29%
Nov 25	-66.01%
Nov 25	-67.29%
Nov 25	-64.89%
Nov 25	-59.39%
Oct 25	-57.76%
Oct 25	-53.62%
Oct 25	-57.35%
Oct 25	-43.13%
Oct 25	-60.12%
Sep 25	-69.04%
Sep 25	-74.18%
Sep 25	-79.94%
Sep 25	-64.91%
Aug 25	-53.71%
Aug 25	-108.35%
Aug 25	-113.91%
Aug 25	-105.47%
Aug 25	-147.67%
Jul 25	-123.24%
Jul 25	-143.38%
Jul 25	-145.83%
Jul 25	-161.98%
Jun 25	-169.7%
Jun 25	-157.23%
Jun 25	-151.94%
Jun 25	-157.73%
May 25	-137.66%
May 25	-157.53%
May 25	-115.48%
May 25	-137.37%
May 25	-165.47%
Apr 25	-174.11%
Apr 25	-138.34%
Apr 25	-185.52%
Apr 25	-189.38%
Mar 25	-189.3%
Mar 25	-170.72%
Mar 25	-176.63%
Mar 25	-95.94%
Feb 25	-123.07%
Feb 25	-137.57%
Feb 25	-143.85%
Feb 25	-165.84%
Jan 25	-93.74%
Jan 25	-138.75%
Jan 25	-133.37%
Jan 25	-138.73%
Jan 25	-154.07%
Dec 24	-177.38%
Dec 24	-142.89%
Dec 24	-137.66%
Dec 24	-129.94%
Nov 24	-122.22%
Nov 24	-109.34%
Nov 24	-87.05%
Nov 24	-93.93%
Nov 24	-156.65%
Oct 24	-176.55%
Oct 24	-166.08%

Price to Sales

NUMIF Price to Sales by year
Period	Price to Sales
Sep 26	1.79
Sep 26	2
Aug 26	2.26
Aug 26	2.3
Aug 26	2.12
Aug 26	2.06
Jul 26	1.8
Jul 26	2.35
Jul 26	2.28
Jul 26	1.78
Jul 26	1.25
Jun 26	1.28
Jun 26	1.18
Jun 26	1.41
Jun 26	1.4
May 26	1.34
May 26	2.69
May 26	2.34
May 26	2.9
May 26	1.44
Apr 26	2.62
Apr 26	0.56
Apr 26	0.53
Apr 26	0.56
Mar 26	0.53
Mar 26	1.28
Mar 26	1.55
Mar 26	1.64
Feb 26	1.83
Feb 26	1.95
Feb 26	1.84
Feb 26	1.85
Jan 26	1.85
Jan 26	2.24
Jan 26	1.96
Jan 26	2.13
Jan 26	2.26
Dec 25	1.98
Dec 25	2.08
Dec 25	1.91
Dec 25	1.92
Nov 25	-3.3
Nov 25	-3.24
Nov 25	-3.36
Nov 25	-3.67
Oct 25	-3.77
Oct 25	-4.06
Oct 25	-3.8
Oct 25	-5.05
Oct 25	-3.62
Sep 25	-3.16
Sep 25	-2.94
Sep 25	-2.73
Sep 25	-3.36
Aug 25	-4.06
Aug 25	-6.52
Aug 25	-6.21
Aug 25	-6.7
Aug 25	-4.79
Jul 25	-5.74
Jul 25	-4.93
Jul 25	-4.85
Jul 25	-4.36
Jun 25	-4.17
Jun 25	-4.5
Jun 25	-4.65
Jun 25	-4.48
May 25	-5.13
May 25	-3.43
May 25	-4.68
May 25	-3.94
May 25	-3.27
Apr 25	-3.11
Apr 25	-3.91
Apr 25	-2.92
Apr 25	-2.86
Mar 25	-2.86
Mar 25	-3.17
Mar 25	-3.06
Mar 25	-5.64
Feb 25	-4.39
Feb 25	10.05
Feb 25	9.61
Feb 25	8.34
Jan 25	14.75
Jan 25	9.96
Jan 25	10.37
Jan 25	9.97
Jan 25	8.97
Dec 24	7.79
Dec 24	9.68
Dec 24	10.04
Dec 24	10.64
Nov 24	11.31
Nov 24	0.78
Nov 24	0.98
Nov 24	0.91
Nov 24	0.54
Oct 24	0.48
Oct 24	0.51

Price/Operating Cashflow

NUMIF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	9.8
Sep 26	11
Aug 26	8.68
Aug 26	8.83
Aug 26	8.17
Aug 26	7.91
Jul 26	6.92
Jul 26	9.02
Jul 26	8.77
Jul 26	6.83
Jul 26	4.8
Jun 26	4.92
Jun 26	4.54
Jun 26	5.41
Jun 26	5.37
May 26	5.15

Price to Book

NUMIF Price to Book by year
Period	Price to Book
Feb 25	18.22
Feb 25	17.42
Feb 25	15.11
Jan 25	26.73
Jan 25	18.06
Jan 25	18.79
Jan 25	18.06
Jan 25	16.27
Dec 24	14.13
Dec 24	17.54
Dec 24	18.2
Dec 24	19.29
Nov 24	20.5
Nov 24	2.9
Nov 24	3.64
Nov 24	3.37
Nov 24	2.02
Oct 24	1.79
Oct 24	1.91
Oct 24	1.95
Oct 24	2.1
Sep 24	1.93
Sep 24	1.93
Sep 24	1.98
Sep 24	1.94
Aug 24	2.06
Aug 24	0.84
Aug 24	0.86
Aug 24	1.12
Aug 24	1.14
Jul 24	1.14
Jul 24	1.29
Jul 24	1.22
Jul 24	1.11
Jun 24	1.22
Jun 24	1.36
Jun 24	1.32
Jun 24	1.32
May 24	1.72
May 24	1.81
May 24	1.82
May 24	2.02
May 24	1.85
Apr 24	2.06
Apr 24	2.17
Apr 24	2.65
Apr 24	2.94
Mar 24	2.69
Mar 24	2.44
Mar 24	2.74
Mar 24	3.09
Mar 24	3
Feb 24	2.1
Feb 24	2.31
Feb 24	2.25
Feb 24	2.36
Jan 24	2.8
Jan 24	2.75
Jan 24	3.23
Jan 24	2.98
Dec 23	2.05
Dec 23	2.27
Dec 23	2.18
Dec 23	2.06
Dec 23	2.51
Nov 23	1.21
Nov 23	1.27
Nov 23	1.45
Nov 23	1.66
Oct 23	1.47
Oct 23	1.75
Oct 23	1.83
Oct 23	1.94
Sep 23	2.06
Sep 23	2.14
Sep 23	2.69
Sep 23	2.27
Sep 23	2.3
Aug 23	1.58
Aug 23	1.59
Aug 23	1.63
Aug 23	1.82
Jul 23	1.86
Jul 23	1.93
Jul 23	2.19
Jul 23	2.13
Jun 23	1.99
Jun 23	2.15
Jun 23	2.04
Jun 23	1.86
Jun 23	2.01
May 23	1.33
May 23	1.1
May 23	1.13
May 23	1.18
Apr 23	1.27
Apr 23	1.3
Apr 23	1.34
Apr 23	1.58
Mar 23	1.45

No video analysis for this stock yet. Request one from our team.

News: NUMIF

newsfilecorp.com · 1 Sep 2026

Numinus Wellness Inc. Provides Corporate Update

All financial results are reported in Canadian dollars unless otherwise stated. Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Numinus Wellness Inc. (OTC Pink: NUMIF) ("Numinus" or the "Company") a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced that it has filed all quarterly interim financial reports for fiscal year 2026 to May 31, 2026.

newsfilecorp.com · 28 Aug 2026

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update

Q4 Fiscal 2025 Highlights Revenue of $2.3 million, a 29.0% increase over Q3 2025 Gross profit of $1.4 million, compared to a gross profit of $0.8 million in Q3 2025 Cash position of $0.5 million as of August 31, 2025 Subsequent to Quarter End On April 18, 2026, President Donald Trump signed an executive order directing U.S. federal agencies to accelerate research, access, and regulatory review for psychedelic-based treatments, including psilocybin, ibogaine, MDMA, and LSD, and committing US$50 million in federal support for state-level programs. The Company views this as a meaningful regulatory development for its clinical research operations and practitioner training programs, both of which are actively engaged in psychedelic research delivery and practitioner readiness.

AI Analysis

Numinus Wellness Inc.

Video analysis: NUMIF

News: NUMIF

Numinus Wellness Inc. Provides Corporate Update

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update

Similar companies